| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Growth Equity Opportunities 17, LLC | 12% | $87.4M | 24.5M | Growth Equity Opportunities 17, LLC | 12 Nov 2025 | |||
| Farallon Capital Partners, L.P. | 9.99% | $58.2M | 18.3M | Dapice Joshua J. | 31 Dec 2024 | |||
| Bain Capital Life Sciences Fund II, L.P. | 9.99% | $56M | 17.6M | Bain Capital Life Sciences Fund II, L.P. | 25 Mar 2025 | |||
| Flynn James E | 6.74% | $48.4M | 13.6M | Deerfield Mgmt, L.P. | 30 Oct 2025 | |||
| Venrock Healthcare Capital Partners III, L.P. | 7.3% | +42% | $45.3M | $13.1M | 12.7M | +40.6% | Venrock Healthcare Capital Partners III, L.P. | 30 Sep 2025 |
| Nantahala Capital Management, LLC | 5.08% | $31.3M | 8.78M | Nantahala Capital Management, LLC | 30 Sep 2025 | |||
| BlackRock, Inc. | 4.8% | $29.7M | 8.31M | BlackRock, Inc. | 30 Sep 2025 | |||
| Frazier Life Sciences Public Fund, L.P. | 3.9% | -38.6% | $16.1M | -$11.3M | 6.75M | -41.2% | Frazier Life Sciences Public Fund, L.P. | 30 Jun 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.2% | $17.4M | 5.48M | Wellington Management Group LLP | 31 Dec 2024 | |||
| Vestal Point Capital, LP | 2.3% | -66.7% | $14.3M | -$24.1M | 4.02M | -62.7% | Vestal Point Capital, LP | 30 Sep 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 163M | $582M | -$17.7M | $3.57 | 123 |
| 2025 Q2 | 168M | $382M | +$4.6M | $2.28 | 121 |
| 2025 Q1 | 165M | $457M | +$4.91M | $2.77 | 133 |
| 2024 Q4 | 163M | $500M | -$4.52M | $3.07 | 134 |
| 2024 Q3 | 160M | $680M | +$47.6M | $4.24 | 124 |
| 2024 Q2 | 148M | $597M | +$107M | $4.03 | 130 |
| 2024 Q1 | 121M | $603M | +$12M | $4.98 | 119 |
| 2023 Q4 | 119M | $559M | +$9.05M | $4.70 | 97 |
| 2023 Q3 | 117M | $441M | +$105M | $3.78 | 83 |
| 2023 Q2 | 89.1M | $285M | +$19.8M | $3.20 | 76 |
| 2023 Q1 | 83.5M | $163M | +$6.96M | $1.95 | 67 |
| 2022 Q4 | 80M | $124M | +$92.9K | $1.55 | 52 |
| 2022 Q3 | 79.9M | $124M | +$4.25M | $1.55 | 47 |
| 2022 Q2 | 77.2M | $117M | +$2.43M | $1.52 | 47 |
| 2022 Q1 | 75.8M | $99.3M | +$1.53M | $1.31 | 45 |
| 2021 Q4 | 74.7M | $92.6M | -$977K | $1.24 | 45 |
| 2021 Q3 | 75M | $104M | -$1.89M | $1.38 | 54 |
| 2021 Q2 | 76.2M | $130M | +$1.31M | $1.70 | 69 |
| 2021 Q1 | 75.2M | $156M | +$112M | $2.08 | 77 |
| 2020 Q4 | 21.7M | $24.9M | -$597K | $1.15 | 61 |
| 2020 Q3 | 17.1M | $18.6M | -$4.01M | $1.09 | 62 |
| 2020 Q2 | 19.6M | $48.8M | +$1.74M | $2.49 | 68 |
| 2020 Q1 | 18.9M | $39.9M | +$5.88M | $2.12 | 66 |
| 2019 Q4 | 20.8M | $92.7M | +$30.7M | $4.48 | 73 |
| 2019 Q3 | 15.2M | $40.2M | -$4.11M | $2.65 | 68 |
| 2019 Q2 | 17M | $40.3M | -$12.8M | $2.37 | 73 |
| 2019 Q1 | 16.4M | $121M | -$5.36M | $7.37 | 79 |
| 2018 Q4 | 17.1M | $129M | -$12.4M | $7.57 | 74 |
| 2018 Q3 | 18M | $201M | +$36.3M | $11.16 | 78 |
| 2018 Q2 | 14.7M | $167M | +$22.1M | $11.32 | 73 |
| 2018 Q1 | 13M | $119M | +$8.22M | $9.20 | 57 |
| 2017 Q4 | 11.7M | $173M | +$108M | $14.84 | 47 |
| 2017 Q3 | 4.42M | $41.5M | +$5.01M | $9.35 | 16 |
| 2017 Q2 | 3.98M | $23.4M | +$23.4M | $5.88 | 16 |
| 2016 Q2 | 0 | $0 | -$1K | 0 | |
| 2016 Q1 | 142 | $1K | $7.04 | 1 |